Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV483
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,434
Award facts
- Contract value 100% obligated
- $44,433.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $44,433.77 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, which is not set-aside for any specific business type, represents a competitively awarded transaction supporting federal pharmaceutical procurement needs. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, reflecting the breadth of pharmaceutical products delivered through federal medical supply channels.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle running through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC relationship with the DLA and serves as the umbrella contract vehicle for numerous task orders supplying essential pharmaceutical products, medical devices, vaccines, and specialized medical commodities to military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal medical institutions worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains significant federal contract capacity to fulfill diverse medical supply requirements across multiple therapeutic domains in support of military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV483?
SPE2DR26FV483 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV483 worth?
The government has obligated $44,434 on SPE2DR26FV483.
Is contract SPE2DR26FV483 an order under another contract?
Yes. SPE2DR26FV483 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV483 competed?
The extent of competition for SPE2DR26FV483 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award